A predictive model for identifying candidates for adjuvant chemotherapy based on recurrence risk profile of resected, node-negative (N0) non-small cell lung cancer

BACKGROUND: The decision for administering adjuvant chemotherapy (AC) in completely resected node-negative non-small cell lung cancer (NSCLC) is guided by likelihood of disease recurrence or death based on tumor, node, metastasis (TNM) stage. However, within each TNM stage are sub-groups of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Krivitsky, Timur A., Wright, Gavin M., Al Zaidi, Muteb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867833/
https://www.ncbi.nlm.nih.gov/pubmed/33569195
http://dx.doi.org/10.21037/jtd-20-2434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867833/
https://www.ncbi.nlm.nih.gov/pubmed/33569195
http://dx.doi.org/10.21037/jtd-20-2434

Ejemplares similares